Analyze Diet

Topic:Pharmacodynamics

Pharmacodynamics in horses refers to the study of how drugs affect the equine body, encompassing the mechanisms of action, the relationship between drug concentration and effect, and the duration of these effects. This field examines how drugs interact with biological systems in horses to produce therapeutic or adverse effects. Key aspects include receptor binding, post-receptor effects, and chemical interactions. Understanding pharmacodynamics is essential for determining appropriate dosages, predicting drug interactions, and assessing therapeutic outcomes in equine medicine. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacodynamic properties of various drugs in horses, focusing on their effects, efficacy, and safety profiles.
Variations in urinary gamma glutamyl transferase/urinary creatinine ratio in horses with or without pleuropneumonia treated with gentamicin.
Equine veterinary journal    May 1, 1995   Volume 27, Issue 3 217-220 doi: 10.1111/j.2042-3306.1995.tb03065.x
Rossier Y, Divers TJ, Sweeney RW.The urinary GGT/urinary creatinine (uGGT/uCR) ratio was measured on Days 1, 3 and 10 in 4 adult, healthy horses; in 6 adult, healthy horses treated with gentamicin at recommended dosages and 9 adult horses treated for pleuropneumonia with gentamicin at recommended dosages. Plasma creatinine and gentamicin trough concentrations were measured on the same days. The uGGT/uCr ratio was higher in the normal horses (mean +/- s.d. 22.85 +/- 13.69) than previously reported normal values (10.5 +/- 6.8) (Adams and McClure 1985). Analysis of variance for repeated measures was used to compare the ratio in ...
Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses.
American journal of veterinary research    March 1, 1995   Volume 56, Issue 3 358-361 
Soraci A, Benoit E, Jaussaud P, Lees P, Delatour P.Carprofen (CPF) enantiomers and their glucuronide conjugates (GLUC) were measured in plasma and bile of horses after IV administration of the racemic compound (0.7 mg/kg of body weight). The CPF was detectable in plasma for up to 72 hours after dosing, whereas GLUC appeared early (time for maximal plasma concentration, 1 hour) and was measurable transiently at low concentration (maximal plasma concentration, 0.5 microgram/ml). The enantiospecific plasma profiles indicated a clear predominance of R-CPF, whereas the stereoselectivity of the glucuronides favored S-GLUC. At 1, 2, and 12 hours afte...
Treatment of atrial fibrillation in horses: new perspectives.
Journal of veterinary internal medicine    March 1, 1995   Volume 9, Issue 2 57-67 doi: 10.1111/j.1939-1676.1995.tb03274.x
Reef VB, Reimer JM, Spencer PA.Forty-one horses were treated for atrial fibrillation (AF) with 22 mg/kg quinidine sulfate via nasogastric tube every 2 hours until conversion to sinus rhythm, a cumulative dose of 88 to 132 mg/kg had been administered in 2-hour increments, or the horse had adverse or toxic effects from the drug. Treatment intervals were prolonged to every 6 hours if conversion had not occurred. Digoxin was administered before treatment if the horse had a fractional shortening < or = 27% (3 horses), was prone to tachycardia (resting heart rate > or = 60 beats/min) (1 horse), or had a previous history of sustai...
[Demonstration of two trimethoprim/sulfonamide combinations in bronchoalveolar lavage fluid of horses and determination of blood levels].
Tierarztliche Praxis    February 1, 1995   Volume 23, Issue 1 59-65 
Fey K, Klatt P, Schmidt H, Sasse HH.Five healthy horses were given a sulfadoxine/trimethoprim combination (Borgal, Hoechst AG) i.v. on day 1. The next ten days the horses got once a day a sulfadimethoxine/trimethoprim combination orally (Trafigal, Hoechst AG). The doses were given as recommended. One horse received no medicaments for control. On each horse six bronchoalveolar lavages were performed. Blood samples were taken to calculate blood levels and elimination half lives. To determine the amount of substances in lavage fluid and plasma the high performance liquid chromatography (HPLC) was used. Regularly low quantities of s...
Allometry of pharmacokinetics and pharmacodynamics of the muscle relaxant metocurine in mammals.
The American journal of physiology    January 1, 1995   Volume 268, Issue 1 Pt 2 R85-R91 doi: 10.1152/ajpregu.1995.268.1.R85
Gronert GA, Fung DL, Jones JH, Shafer SL, Hildebrand SV, Disbrow EA.We investigated the effects of body size on the pharmacokinetics and pharmacodynamics of the renally cleared muscle relaxant metocurine. We hypothesized that pharmacokinetics of the drug would change allometrically in proportion to physiological time [infinity Mb0.25, where Mb is body mass] and that pharmacodynamics would be independent of size because of the highly conserved structure of the acetylcholine receptor. Metocurine effects during general anesthesia were examined in 17 rats, 8 cats, 6 dogs, 5 pigs, 7 sheep, and 12 horses. Allometric analysis demonstrated size dependence for pharmaco...
Absorption and dosage of theophylline in the horse after single and repeated administration of a microencapsulated preparation.
Equine veterinary journal    January 1, 1995   Volume 27, Issue 1 13-18 doi: 10.1111/j.2042-3306.1995.tb03026.x
Roncada P, Tomasi L, Montesissa C, Grossi G, Stracciari GL, Anfossi P.The kinetics of 2 formulations of theophylline were studied in horses. In an initial cross-over study (Phase I) serum concentration-time curves were determined for granulated and microencapsulated theophylline after a single oral administration (5 mg/kg bwt). In Phase II microencapsulated theophylline was administered at 5 mg/kg bwt/12 h for 10 days at feeding time, as in normal clinical practice. Although no significant differences between the 2 preparations were found with respect to the main kinetic parameters, the microencapsulated form was more evenly and completely absorbed from the dige...
Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling.
Journal of veterinary pharmacology and therapeutics    December 1, 1994   Volume 17, Issue 6 459-469 doi: 10.1111/j.1365-2885.1994.tb00278.x
Toutain PL, Autefage A, Legrand C, Alvinerie M.The purpose of the present study was to establish in the horse the relationship between plasma concentration profiles of phenylbutazone (PBZ) and flunixin meglumine (FM) and their pharmacological effects in order to build a predictive pharmacokinetic/pharmacodynamic (PK/PD) model. In five horses, an experimental arthritis was induced by injecting Freund's adjuvant into a carpal joint. PBZ (4 mg/kg) and FM (1 mg/kg) were injected by the intravenous route as a single intravenous dose in two different trials. Five pharmacodynamic end-points were regularly measured after test article injection usi...
Models for assessing the relationship between drug concentration and drug effect in performance horses.
The British veterinary journal    November 1, 1994   Volume 150, Issue 6 507-525 doi: 10.1016/S0007-1935(94)80034-0
Kamerling SG, Owens JG.The actions of most drugs are dependent upon achieving adequate plasma concentrations. Plasma concentrations are influenced by the degree to which a drug is absorbed, distributed, metabolized and excreted. Pharmacokinetic assessment reflects changes in these variables as a function of time. Pharmacodynamics refers to specific drug effects or mechanisms of drug action. Individual drug pharmacokinetics provides information on which to base a therapeutic dose, route of administration and dosing interval. However, not all drug actions temporally correlate with plasma kinetics. To resolve this disc...
Effect of phenylephrine on hemodynamics and splenic dimensions in horses.
American journal of veterinary research    November 1, 1994   Volume 55, Issue 11 1570-1578 
Hardy J, Bednarski RM, Biller DS.Pharmacologically induced splenic contraction might be useful during certain medical or surgical procedures in horses. The effects of phenylephrine, an alpha 1-adrenergic receptor agonist, on hemodynamic function and splenic dimensions were examined in 6 healthy adult horses. Phenylephrine infusion (1, 3, or 6 micrograms/kg of body weight/min for 15 minutes) resulted in a dose-related increase in mean pulmonary artery pressure; right atrial pressure; systolic, mean, and diastolic arterial pressures; and packed cell volume (P = 0.0001). Concurrent decreases in heart rate and specific cardiac ou...
Disposition of human drug preparations in the horse. III. Orally administered alclofenac.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 353-358 doi: 10.1111/j.1365-2885.1994.tb00258.x
Delbeke FT, Landuyt J, Debackere M.Concentrations of the non-steroidal anti-inflammatory drug (NSAID) alclofenac were determined by a sensitive high performance liquid chromatographic procedure in plasma and urine of horses following oral administration of a dose of 3 g. In plasma, alclofenac was present in detectable concentrations for 72 h. The plasma disposition in individual horses was best described by a bi-compartmental model with two successive rate constants ka1 = 0.05 +/- 0.06 h-1 and ka2 = 0.06 +/- 0.01 h-1. Alclofenac half-lives t1/2 alpha and t1/2 beta were 1.0 +/- 0.8 h and 6.9 +/- 1.5 h, respectively. Maximal conc...
Pharmacokinetics and pharmacodynamics of acepromazine in horses.
American journal of veterinary research    October 1, 1994   Volume 55, Issue 10 1428-1433 
Marroum PJ, Webb AI, Aeschbacher G, Curry SH.A specific, sensitive, reverse-phase high-performance liquid chromatographic assay for acepromazine, with analytic sensitivity as low as 5 ng/ml of plasma, and electrochemical detection with an oxidation potential of 0.7 V, was used to study the pharmacokinetics of acepromazine given at a dosage of 0.15 mg/kg of body weight in horses. The relation between effect and pharmacokinetics of the drug was examined. The effects studied included those on blood pressure, pulse, PCV, measures of respiration function, and sedation. Intravenously administered doses led to a biphasic concentration decay pat...
Effects of phenylbutazone on thiamylal disposition and anaesthesia in ponies.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 389-393 doi: 10.1111/j.1365-2885.1994.tb00265.x
Young DB, Ewing PJ, Burrows GE, Lessley BA, Clarke CR, Shawley RV.Phenylbutazone given during the perisurgical period has been reported to increase the intensity and duration of thiamylal anaesthesia in horses. A possible mechanism of competitive plasma protein binding has been suggested. The purpose of the present study was to experimentally reproduce the phenomenon of increased intensity and/or duration of thiamylal anaesthesia and to determine if there is competitive displacement of plasma protein bound thiamylal by phenylbutazone. Six ponies each received one of three treatments, 11 mg/kg intravenous (i.v.) thiamylal; 8.8 mg/kg i.v. phenylbutazone; and 1...
The effects of aspirin and paracetamol on the aggregation of equine blood platelets.
Journal of veterinary pharmacology and therapeutics    October 1, 1994   Volume 17, Issue 5 374-378 doi: 10.1111/j.1365-2885.1994.tb00262.x
Heath MF, Evans RJ, Poole AW, Hayes LJ, McEvoy RJ, Littler RM.The responses of equine blood platelets in citrated platelet-rich plasma to arachidonic acid, U44069 (prostaglandin endoperoxide analogue), adenosine 5'-diphosphate, platelet-activating factor or collagen were investigated by turbidimetric aggregometry. Pre-treatment of the platelets with aspirin (1 mmol/l) or paracetamol (1.3 mmol/l) abolished shape change and aggregation in response to arachidonic acid; decreased the rate of aggregation in response to collagen, with no separate effect on shape change; had no marked effect on aggregation caused by the other agonists; but in no case transforme...
The effects of butorphanol on locomotor activity in ponies: a preliminary study.
Journal of veterinary pharmacology and therapeutics    August 1, 1994   Volume 17, Issue 4 323-326 doi: 10.1111/j.1365-2885.1994.tb00253.x
Nolan AM, Besley W, Reid J, Gray G.No abstract available
The pharmacokinetics and pharmacodynamics of procainamide in horses after intravenous administration.
Journal of veterinary pharmacology and therapeutics    August 1, 1994   Volume 17, Issue 4 265-270 doi: 10.1111/j.1365-2885.1994.tb00243.x
Ellis EJ, Ravis WR, Malloy M, Duran SH, Smyth BG.Six horses were administered either 15 or 20 mg/kg body weight (b.w.) procainamide (PA) as an intravenous (i.v.) dose over 10 min. The plasma concentrations of PA and N-acetylprocainamide (NAPA) as well as the pharmacodynamic effect (prolongation of the QT interval) were monitored. The PA plasma concentrations could be described by a one-compartment model with a t1/2 of 3.49 +/- 0.61 h. The total body clearance of PA was 0.395 +/- 0.090 l/hr/kg and the volume of distribution was 1.93 +/- 0.27 l/kg. As observed after PA administration, NAPA (an active metabolite) had a t1/2 longer than PA of 6....
Kinetics of inhibition of replication of vesicular stomatitis virus in blood mononuclear cells of horses after in vitro and in vivo treatment with recombinant equine interferon-beta 1.
American journal of veterinary research    August 1, 1994   Volume 55, Issue 8 1093-1100 
Marquardt J, Heymer J, Heinz H, Adolf GR, Deegen E.Recombinant equine interferon-beta 1 (reqIFN-beta 1) induces an antiviral state in blood mononuclear cells (BMC) of horses. Maximal protection against replication of vesicular stomatitis virus is achieved 6 hours after treatment with IFN in vitro and in vivo. Duration of the protective effect depends on the dose of IFN in vitro and in vivo. Availability of reqIFN-beta 1 in cultures of BMC for up to 48 hours does not prolong the antiviral state. The protective effect on BMC after treatment with IFN has similar duration in vivo and in vitro. Monitoring of the effect of IFN in vivo is, thus, simp...
Anecdotes and clinical trials: the story of clenbuterol.
Equine veterinary journal    July 1, 1994   Volume 26, Issue 4 256-258 doi: 10.1111/j.2042-3306.1994.tb04384.x
Derksen FJ.No abstract available
Oxytocin enhances clearance of radiocolloid from the uterine lumen of reproductively normal mares and mares susceptible to endometritis.
Equine veterinary journal    July 1, 1994   Volume 26, Issue 4 279-282 doi: 10.1111/j.2042-3306.1994.tb04387.x
LeBlanc M, Neuwirth L, Mauragis D, Klapstein E, Tran T.The effects of oxytocin on the percentage of technetium 99m albumin colloid (99mTc-microAA), cleared from the uterine lumen was measured in 13 mares. Scintigraphy was performed during 4 consecutive oestrous cycles, on Day 3 of oestrus during Cycles one and 3 and 48 h after ovulation during Cycles 2 and 4. Oxytocin (20 iu) was given i.v. after the initial scintigraphy image during Cycles 3 and 4. Seven multiparous mares (Group 1) were classified as 'susceptible' and 6 mares (2 nulliparous and 4 multiparous; Group 2) were classified as 'resistant' to endometritis. All mares cleared > 90% of 99mT...
Effect of sodium cromoglycate on light racehorses with elevated metachromatic cell numbers on bronchoalveolar lavage and reduced exercise tolerance.
Journal of veterinary pharmacology and therapeutics    June 1, 1994   Volume 17, Issue 3 237-244 doi: 10.1111/j.1365-2885.1994.tb00239.x
Hare JE, Viel L, O'Byrne PM, Conlon PD.Some young horses with clinical signs of small airway disease demonstrate increased metachromatic cell numbers on bronchoalveolar lavage. The purpose of this study was to determine the effect of sodium cromoglycate treatment on clinical signs, bronchoalveolar lavage cytology and bronchoalveolar lavage histamine parameters in these horses. Twelve racehorses (age: 3.4 +/- 1.6 years) with a history of respiratory embarrassment at exercise, clinical signs of obstructive airway disease and bronchoalveolar lavage metachromatic cell differential greater than 2% were selected. Horses were randomly ass...
Pharmacokinetics of ketamine in mules and mammoth asses premedicated with xylazine.
Equine veterinary journal    May 1, 1994   Volume 26, Issue 3 241-243 doi: 10.1111/j.2042-3306.1994.tb04377.x
Matthews NS, Taylor TS, Hartsfield SM, Hayton WL, Jones DH.No abstract available
Pharmacodynamics and pharmacokinetics of carprofen in the horse.
Equine veterinary journal    May 1, 1994   Volume 26, Issue 3 203-208 doi: 10.1111/j.2042-3306.1994.tb04370.x
Lees P, McKellar Q, May SA, Ludwig B.The pharmacokinetics and pharmacodynamics of the nonsteroidal anti-inflammatory drug (NSAID) carprofen have been evaluated in 6 horses using a model of acute non-immune inflammation. Following intravenous administration of 0.7 mg racemic carprofen/kg bwt, mean values for pharmacokinetic parameters were 18.1 h (elimination half-life); 0.25 l/kg (volume of distribution, Vd[area]); 58.9 ml/min (clearance); and 57.9 micrograms/ml.h (area under plasma concentration time curve). Mean exudate:plasma concentration ratios exceeded 1.0 at all sampling times between 2 and 48 h. Swelling at the site of ac...
Interaction of gentamycin and atracurium in anaesthetised horses.
Equine veterinary journal    May 1, 1994   Volume 26, Issue 3 209-211 doi: 10.1111/j.2042-3306.1994.tb04371.x
Hildebrand SV, Hill T.Evoked hind limb digital extensor tension (hoof twitch) was maintained at 40% of baseline for 1 h by atracurium infusion in 7 horses anaesthetised with halothane. After 1 h, atracurium was discontinued and hoof twitch allowed to recover to 75%. Atracurium was again given by infusion to maintain 40% twitch for a second hour, then 2 mg gentamycin/kg bwt were given i.v. Atracurium infusion was continued for a third hour, and then hoof twitch was again allowed to recover spontaneously to 75%. Gentamycin reduced twitch strength from 40 +/- 1% (mean +/- sem) to 29 +/- 4% within 7.0 +/- 1.5 min (P = ...
Participation of alpha 1- and beta 1-adrenoceptors in norepinephrine-induced contraction and relaxation of isolated equine coronary artery in vitro.
The Journal of veterinary medical science    April 1, 1994   Volume 56, Issue 2 353-357 doi: 10.1292/jvms.56.353
Obi T, Kabeyama A, Nishio A.In coronary arterial rings isolated from horse, norepinephrine (NE)(10(-7) - 10(-5) M) induced concentration-dependent contractions which were not influenced by endothelial denudation. Prazosin (alpha 1-antagonist) inhibited the contraction, but yohimbine (alpha 2-antagonist) did not, and propranolol (beta-antagonist) enhanced the contraction. Pretreatment with phentolamine (10(-5) M) (alpha-antagonist) converted the contraction induced by NE to relaxation in coronary rings precontracted with ONO11113 (thromboxane A2 derivative). The relaxation was not influenced by removal of the endothelium,...
Ampicillin and its congener prodrugs in the horse.
The British veterinary journal    March 1, 1994   Volume 150, Issue 2 173-187 doi: 10.1016/S0007-1935(05)80225-8
Sarasola P, McKellar QA.Ampicillin is an antibiotic commonly administered to horses by both the intramuscular (i.m.) and the intravenous (i.v.) route. Its physicochemical properties restrict its absorption after oral administration and explain its rapid elimination from the body. To prolong the effects of ampicillin in the horse, attempts have been made to alter its elimination and absorption rates. The alteration of urinary pH did not change the plasma disposition of the antibiotic but when probenecid was administered concurrently with ampicillin, a significant reduction of total body clearance was achieved. Ampicil...
The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers.
The Canadian veterinary journal = La revue veterinaire canadienne    March 1, 1994   Volume 35, Issue 3 170-173 
Tesarowski DB, Viel L, McDonell WN, Newhouse MT.The purpose of the study was to administer therapeutic aerosol generated by metered-dose inhalers to horses exhibiting clinical signs of heaves using a compact inhalation device developed for human medicine. It was fitted to a custom face mask in order to study the effect of an inhaled beta 2-agonist, fenoterol. Pulmonary function testing was performed on six horses following an acute exacerbation of heaves, characterized by tachypnea, wheezes, crackles, and spasmodic cough. Horses inhaled fenoterol in 1 mg increments administered as one 200 microgram puff every 5-10 s with the recording of da...
Effect of xylazine and ketamine on the pharmacokinetics of alfentanil during halothane anaesthesia.
British journal of anaesthesia    March 1, 1994   Volume 72, Issue 3 345-347 doi: 10.1093/bja/72.3.345
Pascoe PJ, Black WD, Steffey EP.We measured plasma concentrations of alfentanil in two horses after three different randomly ordered treatments. Each horse received halothane in oxygen by mask followed by a bolus dose of alfentanil 60 micrograms kg-1 i.v., halothane in oxygen by mask followed by an i.v. alfentanil infusion for 120 min and xylazine and ketamine followed by halothane and a bolus dose of alfentanil 60 micrograms kg-1 i.v. Halothane was maintained at 1.05-1.07% end-tidal concentration with a PaCO2 of 6-7.3 kPa. The plasma concentration-time curves were similar after bolus and infusion doses of alfentanil with ha...
Concentration of ceftiofur metabolites in the plasma and lungs of horses following intramuscular treatment.
Journal of veterinary pharmacology and therapeutics    February 1, 1994   Volume 17, Issue 1 24-30 doi: 10.1111/j.1365-2885.1994.tb00517.x
Jaglan PS, Roof RD, Yein FS, Arnold TS, Brown SA, Gilbertson TJ.Ceftiofur sodium, a broad spectrum cephalosporin antibiotic approved for veterinary use, is metabolized to desfuroylceftiofur which is conjugated to micro as well as macromolecules. Twelve horses, weighting 442-618 kg, were injected intramuscularly with a single dose of 2.2 mg ceftiofur/kg (1.0 mg/lb) body weight. Blood was collected at various intervals over 24 h after treatment. Three groups of four horses each were euthanized and lungs were collected at 1, 12, and 24 h after treatment. The concentration of desfuroylceftiofur and desfuroylceftiofur conjugates in the plasma and lungs was dete...
Trimethoprim/sulfonamide combinations in the horse: a review.
Journal of veterinary pharmacology and therapeutics    February 1, 1994   Volume 17, Issue 1 64-73 doi: 10.1111/j.1365-2885.1994.tb00524.x
Van Duijkeren E, Vulto AG, Van Miert AS.The indications for use, side-effects, and pharmacokinetic parameters of trimethoprim, sulfonamides and their combinations in the horse are reviewed. Trimethoprim/sulfonamide (TMPS) combinations are used for the treatment of various diseases caused by gram-positive and gram-negative bacteria, including infections of the respiratory tract, urogenital tract, alimentary tract, skin joints and wounds. TMPS combinations can be administered orally, since absorption from the gastrointestinal tract is relatively good. However, peak serum concentrations can vary significantly between individual horses....
Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles.
Journal of veterinary pharmacology and therapeutics    February 1, 1994   Volume 17, Issue 1 17-23 doi: 10.1111/j.1365-2885.1994.tb00516.x
Ewing PJ, Burrows G, MacAllister C, Clarke C.The pharmacokinetic properties of four erythromycin formulations were compared in six adult horses after administration of single and multiple oral doses. Formulations of erythromycin administered were estolate and phosphate given 37.5 mg/kg every 12 h and 25 mg/kg every 8 h, and stearate and ethylsuccinate given 25 mg/kg every 8 h. Areas under the curve (AUC) and maximum plasma erythromycin concentrations (Cmax) were equal or greater (P > or = 0.05) following administration of erythromycin phosphate and stearate compared with those values following administration of erythromycin estolate or e...
The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?
The Journal of rheumatology    February 1, 1994   Volume 21, Issue 2 297-301 
Aviad AD, Houpt JB.Various molecular weight hyaluronic acid (HA) preparations have been injected into joints for the treatment of human and equine osteoarthritis. A therapeutic advantage has been claimed for commercial products with a molecular weight in the range found in normal synovial fluid (SF), compared to lower molecular weight products. But a correlation between molecular weight and efficacy is not borne out by an analysis of the available literature on clinical results. SF viscosity, HA concentration, HA molecular weight and rate of synthesis in joint disease. It is proposed that the beneficial effect o...
1 26 27 28 29 30 41